| Score | |
| CAS | 36861-47-9 |
| antiperspirant/ deodorant (4 products) | |
| exfoliant/ scrub (1 products) | |
| antiperspirant/ deodorant (men's) (1 products) | |
| anti-aging (1 products) | |
| facial moisturizer/ treatment (1 products) | |
| Show all 8 products that contain 4-METHYLBENZYLIDENE CAMPHOR. | |
| how to read the score | |
image source: PubChem |
| ||||||||||||||||||
Function/use(s): Ultraviolet Light Absorber; UV ABSORBER; UV FILTER
About 4-METHYLBENZYLIDENE CAMPHOR: A UV filter not approved as an active ingredient for sunscreen in the U.S., but listed as an inactive ingredient in some products. European researchers cite concerns over thyroid toxicity, hormone dis ... read more
Synonym(s): BICYCLO [2.2.1] HEPTAN-2-ONE, 1,7,7-TRIMETHYL-3- [ (4-METHYLPHENYL) METHYLENE] -; ENACAMENE; 3- (4-METHYLBENZYLIDENE) -DL-CAMPHOR; 1,7,7-TRIMETHYL-3- [ (4-METHYLPHENYL) METHYLENE] BICYCLO [2.2.1] HEPTAN-2-ONE; 1,7,7-TRIMETHYL-3- [ (4-METHYLPHENYL) METHYLENE] - BICYCLO [2.2.1] HEPTAN-2-ONE; 4-METHYLBENZYLIDINE CAMPHOR; 4-METHYL-3-BENZYLIDINE CAMPHOR; BICYCLO (2.2.1) HEPTAN-2-ONE, 1,7,7-TRIMETHYL-3- [ (4-METHYLPHENYL) METHYLENE] -; EUSOLEX 6300; (±) -1,7,7-TRIMETHYL-3- [ (4-METHYLPHENYL) METHYLENE] BICYCLO [2.2.1] HEPTAN-2-ONE; MBC
Use restrictions | ||
|---|---|---|
| type of concern | product conditions | reference |
| Violation of government restrictions - Restricted in cosmetics; use, concentration, or manufacturing restrictions - | SCCP (2006) | |
Endocrine disruption | ||
|---|---|---|
| type of concern | product conditions | reference |
| Human endocrine disruptor - strong evidence | European Commission on Endocrine Disruption | |
| show more | ||
Developmental/reproductive toxicity | ||
|---|---|---|
| type of concern | product conditions | reference |
| One or more animal studies show effects at very low doses | Durrer S, Ehnes C, Fuetsch M et al, 2007 | |
| show more | ||
Persistence and bioaccumulation | ||
|---|---|---|
| type of concern | product conditions | reference |
| Persistent, bioaccumulative in wildlife | OSPAR PBTs - Substances of Possible Concern | |
| Persistent, bioaccumulative in wildlife | Emerging PBTs from peer-reviewed literature | |
| show more | ||
Enhanced skin absorption | ||
|---|---|---|
| type of concern | product conditions | reference |
| Absorbs into the skin | Klinubol P, Asawanonda P, Wanichwecharungruang SP, 2008 | |
| Absorbs into the skin | SCCP (2006) | |
Organ system toxicity (non-reproductive) | ||
|---|---|---|
| type of concern | product conditions | reference |
| Classified as not expected to be potentially toxic or harmful | Environment Canada Domestic Substance List | |
Ecotoxicology | ||
|---|---|---|
| type of concern | product conditions | reference |
| Not suspected to be an environmental toxin | Environment Canada Domestic Substance List | |
Data gaps | ||
|---|---|---|
| type of concern | product conditions | reference |
| Not assessed for safety in cosmetics by industry panel | ||
| 2,817 studies in PubMed science library may include information on the toxicity of this chemical see search results -> | PubMed | |
Government, industry, academic studies and classifications |
||
|---|---|---|
| government/industry list/academic study | appears on list as | classification(s) |
| Environment Canada Domestic Substance List | BICYCLO[2.2.1]HEPTAN-2-ONE, 1,7,7-TRIMETHYL-3-[(4-METHYLPHENYL)METHYLENE]- | ,,,,Y-Bioaccumulative,,,,, |
| European Commission on Endocrine Disruption | 3-(4-METHYLBENZYLIDENE)CAMPHOR | HH-CAT1;WF-CAT3a |
| OSPAR PBTs - Substances of Possible Concern | 1,7,7-TRIMETHYL-3-[(4-METHYLPHENYL)METHYLENE]-BICYCLO(2.2.1)HEPTAN-2-ONE | Chemical of Concern under the OSPAR convention |
| Emerging PBTs from peer-reviewed literature | BICYCLO(2.2.1)HEPTAN-2-ONE, 1,7,7-TRIMETHYL-3-[(4-METHYLPHENYL)METHYLENE]- | Identified as an potential emerging PBT in the scientific literature |
| Inui, 2003 | 4- METHYL-BENZYLIDENE CAMPHOR | Increased VTG plasma concentration in male medaka |
| SCCPNFP, 04 | 4-METHYLBENZYLIDINE CAMPHOR | Increased TSH in combination with elevated T3 or T4, enlarged thyroids and thyroid proliferation suggests a major interference of 4-MBC in thyroid hormone metabolism. |
| SCCPNFP, 04; Gleich, 1988 | 4-METHYLBENZYLIDINE CAMPHOR | There was some retardation of ossification in foetuses of the intermediate and high dose groups.; NOAEL for developmental effects in rats at 10 mg/kg/day |
| SCCP (2006) | 4-METHYLBENZYLIDENE CAMPHOR | The SCCP is of the opinion that presently the safe use of a maximum concentration of 4% 4-MBC in sunscreens cannot be established. |
| SCCP (2006) | 4-METHYLBENZYLIDENE CAMPHOR | About 2% of the dose was absorbed in 6 volunteers through dermal penetration |
| Durrer S, Ehnes C, Fuetsch M et al, 2007 | 4-METHYLBENZYLIDENE CAMPHOR | 4-MBC affects development of male reproductive functions and organs, with a lowest observed adverse effect level of 0.7 mg/kg. |
| Durrer S, Ehnes C, Fuetsch M et al, 2007 | 4-METHYLBENZYLIDENE CAMPHOR | 4-MBC delays male puberty and alters hormone receptor expression in the prostate of rats. |
| Klinubol P, Asawanonda P, Wanichwecharungruang SP, 2008 | 4-METHYLBENZYLIDENE CAMPHOR | At 4.4 mg/cm(2) coverage of UV filter on the baby mouse skin, 1.15 +/- 0.14 % of the applied MBC were detected in the receptor fluid at 24 h after application. |
| Klinubol P, Asawanonda P, Wanichwecharungruang SP, 2008 | 4-METHYLBENZYLIDENE CAMPHOR | At 4.4 mg/cm(2) coverage of UV filter on the baby mouse skin, 2.98 +/- 0.38 % of the applied EHMC was detected in the receptor fluid at 24 h after application. |
| Schlumpf M, Durrer S, Faass O et al, 2008 | 4-METHYLBENZYLIDENE CAMPHOR | A rat study reveals impaired reproductive development in males and females, with a lowest observed adverse effect level of 7 mg/kg. |
| Schlumpf M, Kypke K, Vökt C, Birchler M, Durrer S, Faass O, et al, 2008 | 4-METHYLBENZYLIDENE CAMPHOR | |
Other RTECS® classifications [shown for informational purposes only] |
||
|---|---|---|
| government/industry list/academic study | appears on list as | classification(s) |
| RTECS®- EHP, Environmental Health Perspectives 2002 | 4-METHYLBENZYLIDENE CAMPHOR | • endocrine system - Changes in uterine weight (rat TDLo) • endocrine system - Estrogenic (rat TDLo) |
| RTECS®- Toxicologist 2001 | 4-METHYLBENZYLIDENE CAMPHOR | • endocrine system - Changes in uterine weight (rat TDLo) • endocrine system - Estrogenic (rat TDLo) |
| RTECS®- Toxicologist 2003 | 4-METHYLBENZYLIDENE CAMPHOR | • reproductive - Central nervous system (rat TDLo) • developmental - Viability index (rat TDLo) |
| RTECS®- Toxicology Letters 2001 | 4-METHYLBENZYLIDENE CAMPHOR | • reproductive - Endocrine system (rat TDLo) |
| RTECS®- Toxicology 2004 | 4-METHYLBENZYLIDENE CAMPHOR | • endocrine system - Changes in uterine weight (rat TDLo) |
| RTECS®- Toxicology 2004 | 4-METHYLBENZYLIDENE CAMPHOR | • developmental - Delayed effects (rat TDLo) • reproductive - Litter size (rat TDLo) • reproductive - Urogenital system (rat TDLo) • endocrine system - Changes in uterine weight (rat TDLo) • endocrine system - Estrogenic (rat TDLo) |
| RTECS®- Toxicology 2004 | 4-METHYLBENZYLIDENE CAMPHOR | • endocrine system - Evidence of thyroid hyperfunction (rat TDLo) • liver - Other changes (rat TDLo) • biochemical - Other oxidoreductases (rat TDLo) |
references |
||
|---|---|---|
| government/industry list/academic study | reference | |
| Environment Canada Domestic Substance List | EC (Environment Canada). 2008. Domestic Substances List Categorization. Canadian Environmental Protection Act (CEPA) Environmental Registry. | |
| European Commission on Endocrine Disruption | EU (European Union)- Strategy for Endocrine Disrupters 2007. Commision on endocrin disruption requested by the European Parliament in 1998. | |
| OSPAR PBTs - Substances of Possible Concern | OSPAR (Oslo-Paris). 2002. OSPAR List of Substances of Possible Concern. Secondary OSPAR List of Substances of Possible Concern. Secondary OSPAR. Place Published, OSPAR Convention for the Protection of the Marine Environement of North-East Atlanic. | |
| Emerging PBTs from peer-reviewed literature | Emerging PBTs from peer-reviewed literature | |
| Open scientific literature | {Inui, 2003} | |
| Open scientific literature | {SCCPNFP, 04} | |
| Open scientific literature | {SCCPNFP, 04; Gleich, 1988} | |
| Open scientific literature | SCCP (2006). "Opinion concerning 4-Methylbenzylidene Camphor ". European Commission - The Scientfic Committee on Cosmetic Products and Non-Food Products Intended for Consumers. SCCP/1042/06 Retrieved from http://ec.europa.eu/health/ph_risk/committees/04_sccp/sccp_opinions_en.htm. | |
| Open scientific literature | SCCP (2006). "Opinion concerning 4-Methylbenzylidene Camphor ". European Commission - The Scientfic Committee on Cosmetic Products and Non-Food Products Intended for Consumers. SCCP/1042/06 Retrieved from http://ec.europa.eu/health/ph_risk/committees/04_sccp/sccp_opinions_en.htm. | |
| Open scientific literature | Durrer S, Ehnes C, Fuetsch M et al. "Estrogen sensitivity of target genes and expression of nuclear receptor co-regulators in rat prostate after pre- and postnatal exposure to the ultraviolet filter 4-methylbenzylidene camphor." Environ Health Perspect 2007; 115 Suppl 1:42-50. | |
| Open scientific literature | Durrer S, Ehnes C, Fuetsch M et al. "Estrogen sensitivity of target genes and expression of nuclear receptor co-regulators in rat prostate after pre- and postnatal exposure to the ultraviolet filter 4-methylbenzylidene camphor." Environ Health Perspect 2007; 115 Suppl 1:42-50. | |
| Open scientific literature | Klinubol P, Asawanonda P, Wanichwecharungruang SP. Transdermal penetration of UV filters. Skin Pharmacol Physiol 2008; 21 (1):23-9. | |
| Open scientific literature | Klinubol P, Asawanonda P, Wanichwecharungruang SP. Transdermal penetration of UV filters. Skin Pharmacol Physiol 2008; 21 (1):23-9. | |
| Open scientific literature | Schlumpf M, Durrer S, Faass O et al. "Developmental toxicity of UV filters and environmental exposure: a review." Int J Androl 2008; 31 (2):144-51. | |
| Open scientific literature | Schlumpf M, Kypke K, Vökt C, Birchler M, Durrer S, Faass O, et al. 2008. Endocrine Active UV Filters: Developmental Toxicity and Exposure Through Breast Milk. Chimia 62: 1-7. | |
| RTECS®- EHP, Environmental Health Perspectives 2002 [shown for informational purposes only] | RTECS®- EHP, Environmental Health Perspectives. (U.S. Government Printing Office, Supt of Documents, Washington, DC 20402) No.1- 1972- 110,533,2002 | |
| RTECS®- Toxicologist 2001 [shown for informational purposes only] | RTECS®- Toxicologist. (Soc. of Toxicology, Inc., 475 Wolf Ledge Parkway, Akron, OH 44311) V.1- -1981 60,298,2001 | |
| RTECS®- Toxicologist 2003 [shown for informational purposes only] | RTECS®- Toxicologist. (Soc. of Toxicology, Inc., 475 Wolf Ledge Parkway, Akron, OH 44311) V.1- -1981 72,133,2003 | |
| RTECS®- Toxicology Letters 2001 [shown for informational purposes only] | RTECS®- Toxicology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1977- 135,S85,2001 | |
| RTECS®- Toxicology 2004 [shown for informational purposes only] | RTECS®- Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973- 199,109,2004 | |
| RTECS®- Toxicology 2004 [shown for informational purposes only] | RTECS®- Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973- 205,113,2004 | |
| RTECS®- Toxicology 2004 [shown for informational purposes only] | RTECS®- Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973- 205,95,2004 | |
"RTECS®" is a United States trademark owned and licensed under authority of the U.S. Government, by and through MDL Information Systems, Inc.